Fennec Pharmaceuticals Announces Pedmarqsi® Positive Recommendation by NICE for the Prevention of Cisplatin-Induced Hearing Loss in England and Wales

Published on December 20, 2024

will not be sufficient to fund further development and clinical studies, our ability to obtain necessary capital when needed on acceptable

Continue reading on website
Other news

County in SW China's Chongqing develops thriving cured meat industry

December 20, 2024
a history stretching back over 2,500 years, was listed as an intangible cultural heritage, according to Dong Yifeng, head of the county.

Applied Therapeutics Appoints John H. Johnson as Executive Chairman

December 20, 2024
x) our ability to fund our working capital requirements and expectations regarding the sufficiency of our capital resources, (xi) the